AFT Pharmaceuticals is widely recognized as a leading Australasian multinational pharmaceutical company known for developing, marketing, and distributing a diverse portfolio of proprietary and over-the-counter medicines. The company gained significant industry prominence for its innovative pain management formulations, such as Maxigesic, alongside specialized hospital products, eye care solutions, and allergy treatments. Its strategic focus centers on commercializing intellectual property across domestic markets and expanding distribution into dozens of international countries.